/
/
/

Accretion Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%

Share Price Live Stats

Open (₹)202.00
Volume (₹)13,200.00
High (₹)202.00
Upper Circuit212.10
Low (₹)200.00
Lower Circuit191.90
Prev Close202.00
52W High (₹)214.70
Price200.00
52W Low (₹)53.80

Share Market Cap & Key Ratios Overview

M.Cap (₹)224.54 Cr
Div. Yield (%)0.00
PE Ratio23.23
Debt to Equity0.24
Price to Book1.35
Book Value46.91
EPS (TTM)8.70
Face Value10.00
ROE (%)28.72

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
ACCPL-STNSE
LTP
1W Low
1W High
Market cap (₹)
1899.6-20.4 (-1.06%)
1896.80
1984.80
4,56,833Cr
9144.5-94.5 (-1.02%)
9087
9467
2,45,426Cr
4843-207 (-4.10%)
4823
5066
1,87,320Cr
1130.5-60.5 (-5.08%)
1125.10
1187
1,13,217Cr
1380.5-43 (-3.02%)
1376
1426.10
1,12,212Cr
1843.3-95.2 (-4.91%)
1811.70
1949
1,01,155Cr
2111.2-60.3 (-2.78%)
2107.20
2192
97,626Cr
2331-51.9 (-2.18%)
2327.30
2419.20
96,859Cr
1157.5-20.5 (-1.74%)
1154.40
1179.90
96,406Cr
1654.2+8.9 (0.54%)
1622.60
1717
93,614Cr
200+0.45 (0.23%)
198.20
210
225Cr

Key Highlights of Accretion Pharmaceuticals Ltd’s P&L

In 2026-03-31, Accretion Pharmaceuticals Ltd reported total revenue of ₹89.63Cr, compared with ₹57.38Cr in 2025-03-31, reflecting Accretion Pharmaceuticals Ltd turnover.

Depreciation was ₹1.21Cr and finance costs were ₹87.03Lakh in 2026-03-31

Profit Before Tax (PBT) has been ₹13.08Cr in 2026-03-31 as compared to ₹9.76Cr in 2025-03-31.

Net Profit (PAT) was ₹9.67Cr in 2026-03-31 compared with ₹6.79Cr in 2025-03-31.

Earnings per share (EPS) were ₹8.70 in 2026-03-31, compared with ₹8.32 in 2025-03-31.